Zimmer Biomet Holdings (ZBH) reported results in line with expectations in FY2026 on revenue of $148.0B versus the $149.3B estimate (+26.5% YoY) and EPS of $1.58. Below is the full Zimmer Biomet Holdings earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$148.0B (vs $149.3B est · -0.9% surprise · +26.5% YoY)
EPS
$1.58 (vs $1.58 est · +0.0% surprise · +15.9% YoY)
Share price
$130.68 (-1.4%)
Market cap
$1.28T
What you'll find
Next Zimmer Biomet Holdings (ZBH) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Zimmer Biomet Holdings reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Zimmer Biomet Holdings (ZBH)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Zimmer Biomet Holdings's next earnings date?
Zimmer Biomet Holdings's (ZBH) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Zimmer Biomet Holdings (ZBH) beat or miss earnings?
In FY2026, Zimmer Biomet Holdings (ZBH) posted in-line results — revenue of $148.0B versus the $149.3B estimate (-0.9% surprise) and EPS of $1.58 versus $1.58 expected (+0.0% surprise). Magnisto decodes every Zimmer Biomet Holdings (ZBH) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Zimmer Biomet Holdings (ZBH) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Zimmer Biomet Holdings (ZBH), anchored to the current $130.68 share price, so you can weigh the bull, base and bear cases for Zimmer Biomet Holdings side by side.
Is Zimmer Biomet Holdings (ZBH) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Zimmer Biomet Holdings fits your own thesis and risk profile. This is research, not investment advice.